Improving Access to Rare Disease Treatments: Subsidy, Pricing, and Payment Schemes. - Wendy Olsder; Tugce G. Martagan; Christopher S. Tang (Manag. Sci., 2023)

Converting a drug from off-label to on-label use: Government subsidies and patient welfare. - Wendy Olsder; Tugce G. Martagan; Christopher S. Tang (Decis. Sci., 2023)